Multiple Myeloma

Multiple Myeloma (also known as "plasma cell myeloma", "Kahler’s disease" after Otto Kahler or "Huppert’s disease") is a cancer of the bone marrow. It is characterized by malignant multiplication of antibody-producing cells, the so-called plasma cells. The degenerated plasma cells typically produce antibodies or fragments of it. Since all malignant (i.e. malignant) plasma cells are descended from a common precursor cell, they are genetically identical (cell clone) and produce identical (i.e. monoclonal) antibodies.

The extent of the malignancy can vary ranging from pre-cancerous lesions in slowly progressing disease processes, to highly malignant, rapidly fatal without treatment, leading to death. What is striking is that plasmacytoma occurs mostly in men over the age of 60. It is unclear why plasmacytoma occurs twice as often now than 30 years ago.

Patients complain of fatigue and weight loss, and often pain in the back of the head. The indication of bone pain help the diagnosis (often back pain). This, in contrast to the pain of bone metastases is not at night, but increases during movement with the occurrence of spontaneous fractures. Through the growth of B cells in the bone marrow, there is a dissolving of bone substance and therefore a loss of stability. This grouping in the skull bones is relatively common and typical and referred to as a» pepper-pot-skull.

Characteristic of Multiple Myeloma is a proteinuria (protein in urine) which can eventually lead to damage of the kidneys in addition to an increased excretion of calcium (bone loss). The repression of growth in the bone marrow can cause anaemia, leuco-and thrombocytopenia. An increased vulnerability to infection and clotting disorders can also occur, which becomes apparent through skin bleeding or increased nosebleeds.

The diagnosis is made by blood tests, X-rays of the large bones, and bone marrow biopsy.

Recommended therapies for the treatment of Multiple Myeloma:

Whole body Hyperthermia

For patients with cancers of the bone marrow, the healing effect of whole-body hyperthermia is that we can very quickly bring the body to high temperatures (up 40.5 °). This fast and high heating activates not only the immune system, but many degenerate cells of the bone marrow are destroyed by the rapid floods of heat. In addition to the damage or removal of the cancer cells, the whole-body hyperthermia stimulates the immune system enormously without impacting the rest of the body. It triggers an immune cascade that activates and multiplies the white blood cells.

Gerson therapy

The nutritional therapy of Dr. Gerson, aims at detoxifying the body with the simultaneous addition of many fresh nutrients, which is particularly useful for patients with Multiple Myeloma. The therapy includes special juices, fresh and elaborately prepared and taken throughout the day, along with essentially high-quality fresh fruits and vegetables. These are carefully prepared to retain their healing powers, partly as fresh food, in special soups, or gently cooked and steamed. The Gerson therapy is low in sodium, protein and fat.

Infusion with high-dose Vitamin C

At the Hyperthermia Centre Hannover we treat patients with bone marrow cancer successfully with high-doses of vitamin C. The so-called Ascorbic acid is the most well-known vitamin, – and the most important antioxidant, i.e. it intercepts harmful free radicals in the body and makes them harmless, and in this way prevents degeneration in the cells. Vitamin C is also essential for the immune system and various restructuring processes in the body. When vitamin C is given in a high- dose, the treatment of plasma cell myeloma can be positively affected.